4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -71,317 | -46,234 | -23,995 | -16,406 | -56,693 |
| Depreciation Amortization | 2,242 | 1,133 | 753 | 383 | 1,443 |
| Accounts receivable | 1,439 | 695 | 268 | 521 | -508 |
| Accounts payable and accrued liabilities | 2,285 | 623 | -172 | -601 | 43 |
| Other Working Capital | -15,534 | -13,542 | -15,346 | -2,157 | -711 |
| Other Operating Activity | 11,751 | 10,027 | 6,915 | 2,888 | 5,517 |
| Operating Cash Flow | $-69,134 | $-47,298 | $-31,577 | $-15,372 | $-50,909 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,110 | -4,014 | -1,379 | -642 | -1,000 |
| Purchase Of Investment | -168,570 | -136,375 | 0 | N/A | N/A |
| Sale Of Investment | 5,000 | 0 | 0 | N/A | N/A |
| Investing Cash Flow | $-172,680 | $-140,389 | $-1,379 | $-642 | $-1,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 118,089 | 2,896 | 919 | 99 | 206,515 |
| Other Financing Activity | 0 | -946 | -946 | -946 | 72,468 |
| Financing Cash Flow | $118,089 | $1,950 | $-27 | $-847 | $278,983 |
| Beginning Cash Position | 276,726 | 276,726 | 276,726 | 276,726 | 49,652 |
| End Cash Position | 153,001 | 90,989 | 243,743 | 259,865 | 276,726 |
| Net Cash Flow | $-123,725 | $-185,737 | $-32,983 | $-16,861 | $227,074 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,134 | -47,298 | -31,577 | -15,372 | -50,909 |
| Capital Expenditure | -9,110 | -4,014 | -1,379 | -642 | -1,000 |
| Free Cash Flow | -78,244 | -51,312 | -32,956 | -16,014 | -51,909 |